NCT07454564 Preoperative Cardiac Power Output and P-POSSUM Score
| NCT ID | NCT07454564 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Necmettin Erbakan University |
| Condition | Surgical Risk Assessment |
| Study Type | OBSERVATIONAL |
| Enrollment | 120 participants |
| Start Date | 2026-03-10 |
| Primary Completion | 2026-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 120 participants in total. It began in 2026-03-10 with a primary completion date of 2026-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to investigate the relationship between preoperative Cardiac Power Output (CPO), which reflects the pumping capacity of the heart, and the P-POSSUM score, a widely used surgical risk assessment tool, in patients aged 65 years and older undergoing abdominal surgery. Simple and non-invasive measurements performed in the preoperative period will be used to obtain CPO values and to evaluate whether these measurements are helpful in predicting postoperative morbidity and mortality. No additional procedures beyond routine clinical care will be performed as part of this observational study. The findings of this study may contribute to a more accurate assessment of surgical risk and help improve patient safety in the perioperative period.
Eligibility Criteria
Inclusion Criteria: Being 65 years of age or older, * Undergoing abdominal surgery in general surgery practice (including elective and emergency procedures), * ASA (American Society of Anesthesiologists) class I-III, * Adequate recording with transthoracic echocardiography, * Having given informed consent. Exclusion Criteria:Advanced heart failure with ejection fraction (EF) \<30%, * Severe valvular disease (severe stenosis or insufficiency), * Unstable coronary artery disease or recent myocardial infarction (within the last 3 months), * Pulmonary hypertension, * Severe arrhythmia (uncontrolled atrial fibrillation, ventricular tachycardia, etc.)
Contact & Investigator
ŞULE ARICAN, Assoc. Prof.
PRINCIPAL INVESTIGATOR
Konya Necmettin Erbakan University
Frequently Asked Questions
Who can join the NCT07454564 clinical trial?
This trial is open to participants of all sexes, aged 65 Years or older, studying Surgical Risk Assessment. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07454564 currently recruiting?
Yes, NCT07454564 is actively recruiting participants. Contact the research team at enginkilinc96@gmail.com for enrollment information.
Where is the NCT07454564 trial being conducted?
This trial is being conducted at Konya, Turkey (Türkiye).
Who is sponsoring the NCT07454564 clinical trial?
NCT07454564 is sponsored by Necmettin Erbakan University. The principal investigator is ŞULE ARICAN, Assoc. Prof. at Konya Necmettin Erbakan University. The trial plans to enroll 120 participants.